ANGIODYNAMICS INC
For the period ended Nov 30, 2025. Filed Jan 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Nov 30, 2025 · Filed Jan 6, 2026
ANGO$12.07-0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows (unaudited)
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands of dollars)
| Six Months Ended | ||
|---|---|---|
| Nov 30, 2025 | Nov 30, 2024 | |
| Cash flows from operating activities: | ||
| Net loss | $(17,253) | $(23,536) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 11,767 | 13,648 |
| Non-cash lease expense | 850 | 993 |
| Non-cash interest expense | 145 | — |
| Stock based compensation | 7,361 | 5,733 |
| Change in fair value of contingent consideration | — | 232 |
| Deferred income taxes | (64) | (588) |
| Change in accounts receivable allowances | (127) | 388 |
| Fixed and intangible asset disposals | 280 | 59 |
| Other | 502 | 119 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (1,429) | 50 |
| Inventories | (3,473) | (5,303) |
| Prepaid expenses and other | (2,295) | (72) |
| Accounts payable, accrued and other liabilities | (7,517) | (7,503) |
| Net cash used in operating activities | (11,253) | (15,780) |
| Cash flows from investing activities: | ||
| Additions to property, plant and equipment | (1,153) | (1,889) |
| Additions to placement and evaluation units | (2,019) | (2,477) |
| Net cash used in investing activities | (3,172) | (4,366) |
| Cash flows from financing activities: | ||
| Principal payments on financing arrangement | (183) | — |
| Repurchase of common stock | — | (1,670) |
| Proceeds from exercise of stock options and employee stock purchase plan | 234 | 38 |
| Net cash provided by (used in) financing activities | 51 | (1,632) |
| Effect of exchange rate changes on cash and cash equivalents | 119 | (189) |
| Decrease in cash and cash equivalents | (14,255) | (21,967) |
| Cash and cash equivalents at beginning of period | 55,893 | 76,056 |
| Cash and cash equivalents at end of period | $41,638 | $54,089 |
| Supplemental disclosure of non-cash investing and financing activities: | ||
| Accrual for capital expenditures incurred during the period | $430 | $411 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.